Private Companies
Locust Walk's Framework for Supporting Private Companies
Private biotech companies must have efficient strategies and funding to progress. Our framework supports:
Company and Product Strategy
- Differentiate technology and prioritize development.
- Drive value with key milestones and strategic partnerships
Fundraising
- Address investor needs and secure term sheets.
- Optimize valuation, terms, and syndicate composition.
Strategic Dealmaking
- Choose the right deal (global vs regional, licensing vs M&A).
- Craft compelling messages and identify the right partners.
Locust Walk helps private biotech companies navigate strategic, fundraising, and dealmaking challenges with tailored solutions and expert guidance.
How Locust Walk Engages with Private Biotech Companies
Establish Corporate and Portfolio Strategy
- Optimize program prioritization and identify synergistic technologies for in-licensing.
- Focus on value-maximizing partnerships and financing strategies
Early Platform Collaborations
- Identify partnerships for validation and non-dilutive funding.
- Lead or support deal structuring and valuation.
Externalizing Assets with Partners
- Identify target partners, determine deal timing, and perform valuation analyses.
- Lead or support global and regional partnerships.
Equity Capital Raise
- Craft investor ready story and outreach to institutional investors.
- Lead $50M+ Series B and later raises focused on institutional investors.
- How Locust Walk Engages with Private Biotech Companies
Establish Corporate and Portfolio Strategy
- Optimize program prioritization and identify synergistic technologies for in-licensing.
- Focus on value-maximizing partnerships and financing strategies
Early Platform Collaborations
- Identify partnerships for validation and non-dilutive funding.
- Lead or support deal structuring and valuation.
Externalizing Assets with Partners
- Identify target partners, determine deal timing, and perform valuation analyses.
- Lead or support global and regional partnerships.
Equity Capital Raise
- Craft investor ready story and outreach to institutional investors.
- Lead $50M+ Series B and later raises focused on institutional investors.